Skip to main content
Year archive

SAMIL PHARMACEUTICAL CO.,LTD — 2026 filings

All 23 regulatory filings released by SAMIL PHARMACEUTICAL CO.,LTD (000520) in 2026, sourced directly from the official regulator.

23 Filings
2026 Period
2026 filings (23)
Filing Released Lang
최대주주등소유주식변동신고서
Major Shareholding Notification
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-06 Korean
최대주주등소유주식변동신고서
Regulatory Filings
2026-05-06 Korean
최대주주등소유주식변동신고서
Regulatory Filings
2026-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-26 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2026-03-25 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-18 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
자기주식처분결과보고서
Transaction in Own Shares
2026-02-27 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares
2026-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-26 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경
Regulatory Filings
2026-01-26 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2025
2026-01-26 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2026-01-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-01-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-01-14 Korean